Blood Test Signals Dementia Risk Decades Before Onset
TL;DR Summary
UC San Diego researchers identify plasma phosphorylated tau 217 (p-tau217) as a blood biomarker that predicted future dementia risk decades before symptoms, especially in older women and APOE ε4 carriers; its predictive power varies with age and hormone therapy history, suggesting potential for earlier prevention and monitoring, though not yet ready for routine clinical use.
- A Simple Blood Test Could Predict Dementia Risk 25 Years Early SciTechDaily
- 'Alzheimer’s clock': Highly accurate blood test can predict what age symptoms may start, study finds KTVU
- Heart surgeon with 25 years of experience shares breakthrough blood test that can help detect Alzheimer's risk early Hindustan Times
- One Biomarker, Two Diseases: The p-tau Signal That Just Complicated Your Stratification Strategy The Clinical Trial Vanguard
- Neuberg Diagnostics introduces blood test for Alzheimer’s screening in Chennai expresshealthcare.in
Reading Insights
Total Reads
0
Unique Readers
17
Time Saved
8 min
vs 8 min read
Condensed
96%
1,564 → 55 words
Want the full story? Read the original article
Read on SciTechDaily